Auginia Natalia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Auginia Natalia has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
- Huilin Shao
Institute for Health Innovation & Technology, National University of Singapore, Singapore, Singapore
12 shared publications - Noah Riandiputra Sundah
Institute for Health Innovation & Technology, National University of Singapore, Singapore, Singapore
6 shared publications Yan Zhang
Institute for Health Innovation & Technology, National University of Singapore, Singapore, Singapore
6 shared publications- Nicholas R. Y. Ho
Biomedical Institute for Global Health Research and Technology, National University of Singapore, Singapore, 117599, Singapore
4 shared publications Tze Ping Loh
Institute for Health Innovation & Technology, National University of Singapore, Singapore, Singapore
4 shared publicationsCarine Z. J. Lim
Institute for Health Innovation & Technology, National University of Singapore, Singapore, Singapore
3 shared publications
Latest Publications
- 21 July 2026
- Published by Springer Nature in Nature Nanotechnology
- Vol. 21 (9) , 1327-1337
Catalytic profiling of extracellular vesicles maps altered cancer metabolism
Current technologies for measuring cancer metabolism have limited clinical utility, as they require invasive tissue sampling and lack analytical versatility. Here, we report a programmable nanotechnology platform that directly profiles extracellular vesicles (EVs) in patient biofluids to comprehensively capture metabolic alterations within the tumour milieu. This technology, termed atomically configured catalytic hybrids for profiling extracellular vesicle metabolites (ACTIVE), employs dual-matched biotic–abiotic nanohybrids based on defect-engineered transition-metal dichalcogenide peroxidase to catalytically quantify EV-associated metabolites. Each hybrid comprises a biomimetic peroxidase grown in situ on a metabolite-responsive biological oxidase. By spatially and energetically aligning their redox centres to enable direct electron transfer, these hybrids establish efficient tandem catalytic cascades that detect low-abundance metabolites in complex samples, achieving >30-times-higher catalytic efficiency than wild-type catalysts. In EV profiling applications, ACTIVE enables measurements in native biofluids (>103-fold improvement), captures a broad spectrum of metabolites (including their conversion dynamics) across EV subpopulations from diverse cellular systems and reflects dynamic changes in metabolic pathways during cellular reprogramming. In clinical specimens, using only 5 µl of native ascites fluid, ACTIVE reveals distinct metabolic reprogramming signatures within the tumour milieu, enabling stratification of patient prognosis.
- 21 July 2026
- Published by Springer Nature in Nature Nanotechnology
- Vol. 21 (9) , 1327-1337
Catalytic profiling of extracellular vesicles maps altered cancer metabolism
Current technologies for measuring cancer metabolism have limited clinical utility, as they require invasive tissue sampling and lack analytical versatility. Here, we report a programmable nanotechnology platform that directly profiles extracellular vesicles (EVs) in patient biofluids to comprehensively capture metabolic alterations within the tumour milieu. This technology, termed atomically configured catalytic hybrids for profiling extracellular vesicle metabolites (ACTIVE), employs dual-matched biotic–abiotic nanohybrids based on defect-engineered transition-metal dichalcogenide peroxidase to catalytically quantify EV-associated metabolites. Each hybrid comprises a biomimetic peroxidase grown in situ on a metabolite-responsive biological oxidase. By spatially and energetically aligning their redox centres to enable direct electron transfer, these hybrids establish efficient tandem catalytic cascades that detect low-abundance metabolites in complex samples, achieving >30-times-higher catalytic efficiency than wild-type catalysts. In EV profiling applications, ACTIVE enables measurements in native biofluids (>103-fold improvement), captures a broad spectrum of metabolites (including their conversion dynamics) across EV subpopulations from diverse cellular systems and reflects dynamic changes in metabolic pathways during cellular reprogramming. In clinical specimens, using only 5 µl of native ascites fluid, ACTIVE reveals distinct metabolic reprogramming signatures within the tumour milieu, enabling stratification of patient prognosis.
- Open Access
- 27 September 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-14
Magnetic augmentation through multi-gradient coupling enables direct and programmable profiling of circulating biomarkers
Conventional magnetic biosensing technologies have reduced analytical capacity for magnetic field dimensionality and require extensive sample processing. To address these challenges, we spatially engineer 3D magnetic response gradients for direct and programmable molecular detection in native biofluids. Named magnetic augmentation through triple-gradient coupling for high-performance detection (MATCH), the technology comprises gradient-distributed magnetic nanoparticles encapsulated within responsive hydrogel pillars and suspended above a magnetic sensor array. This configuration enables multi-gradient matching to achieve optimal magnetic activation, response and transduction, respectively. Through focused activation by target biomarkers, the platform preferentially releases sensor-proximal nanoparticles, generating response gradients that complement the sensor’s intrinsic detection capability. By implementing an upstream module that recognizes different biomarkers and releases universal activation molecules, the technology achieves programmable detection of various circulating biomarkers in native plasma. It bypasses conventional magnetic labeling, completes in <60 minutes and achieves sensitive detection (down to 10 RNA and 1000 protein copies). We apply the MATCH to measure RNAs and proteins directly in patient plasma, achieving accurate cancer classification.
- 27 September 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-14
Open AccessMagnetic augmentation through multi-gradient coupling enables direct and programmable profiling of circulating biomarkers
Conventional magnetic biosensing technologies have reduced analytical capacity for magnetic field dimensionality and require extensive sample processing. To address these challenges, we spatially engineer 3D magnetic response gradients for direct and programmable molecular detection in native biofluids. Named magnetic augmentation through triple-gradient coupling for high-performance detection (MATCH), the technology comprises gradient-distributed magnetic nanoparticles encapsulated within responsive hydrogel pillars and suspended above a magnetic sensor array. This configuration enables multi-gradient matching to achieve optimal magnetic activation, response and transduction, respectively. Through focused activation by target biomarkers, the platform preferentially releases sensor-proximal nanoparticles, generating response gradients that complement the sensor’s intrinsic detection capability. By implementing an upstream module that recognizes different biomarkers and releases universal activation molecules, the technology achieves programmable detection of various circulating biomarkers in native plasma. It bypasses conventional magnetic labeling, completes in <60 minutes and achieves sensitive detection (down to 10 RNA and 1000 protein copies). We apply the MATCH to measure RNAs and proteins directly in patient plasma, achieving accurate cancer classification.
- 19 June 2024
- Published by Springer Nature in Nature Biomedical Engineering
- Vol. 8 (7) , 909-923
Bidirectional linkage of DNA barcodes for the multiplexed mapping of higher-order protein interactions in cells
Capturing the full complexity of the diverse hierarchical interactions in the protein interactome is challenging. Here we report a DNA-barcoding method for the multiplexed mapping of pairwise and higher-order protein interactions and their dynamics within cells. The method leverages antibodies conjugated with barcoded DNA strands that can bidirectionally hybridize and covalently link to linearize closely spaced interactions within individual 3D protein complexes, encoding and decoding the protein constituents and the interactions among them. By mapping protein interactions in cancer cells and normal cells, we found that tumour cells exhibit a larger diversity and abundance of protein complexes with higher-order interactions. In biopsies of human breast-cancer tissue, the method accurately identified the cancer subtype and revealed that higher-order protein interactions are associated with cancer aggressiveness.
- 19 June 2024
- Published by Springer Nature in Nature Biomedical Engineering
- Vol. 8 (7) , 909-923
Bidirectional linkage of DNA barcodes for the multiplexed mapping of higher-order protein interactions in cells
Capturing the full complexity of the diverse hierarchical interactions in the protein interactome is challenging. Here we report a DNA-barcoding method for the multiplexed mapping of pairwise and higher-order protein interactions and their dynamics within cells. The method leverages antibodies conjugated with barcoded DNA strands that can bidirectionally hybridize and covalently link to linearize closely spaced interactions within individual 3D protein complexes, encoding and decoding the protein constituents and the interactions among them. By mapping protein interactions in cancer cells and normal cells, we found that tumour cells exhibit a larger diversity and abundance of protein complexes with higher-order interactions. In biopsies of human breast-cancer tissue, the method accurately identified the cancer subtype and revealed that higher-order protein interactions are associated with cancer aggressiveness.
- Open Access
- 17 July 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-14
Multiplexed RNA profiling by regenerative catalysis enables blood-based subtyping of brain tumors
Current technologies to subtype glioblastoma (GBM), the most lethal brain tumor, require highly invasive brain biopsies. Here, we develop a dedicated analytical platform to achieve direct and multiplexed profiling of circulating RNAs in extracellular vesicles for blood-based GBM characterization. The technology, termed ‘enzyme ZIF-8 complexes for regenerative and catalytic digital detection of RNA’ (EZ-READ), leverages an RNA-responsive transducer to regeneratively convert and catalytically enhance signals from rare RNA targets. Each transducer comprises hybrid complexes – protein enzymes encapsulated within metal organic frameworks – to configure strong catalytic activity and robust protection. Upon target RNA hybridization, the transducer activates directly to liberate catalytic complexes, in a target-recyclable manner; when partitioned within a microfluidic device, these complexes can individually catalyze strong chemifluorescence reactions for digital RNA quantification. The EZ-READ platform thus enables programmable and reliable RNA detection, across different-sized RNA subtypes (miRNA and mRNA), directly in sample lysates. When clinically evaluated, the EZ-READ platform established composite signatures for accurate blood-based GBM diagnosis and subtyping.
- 17 July 2023
- Published by Springer Nature in Nature Communications
- Vol. 14 (1) , 1-14
Open AccessMultiplexed RNA profiling by regenerative catalysis enables blood-based subtyping of brain tumors
Current technologies to subtype glioblastoma (GBM), the most lethal brain tumor, require highly invasive brain biopsies. Here, we develop a dedicated analytical platform to achieve direct and multiplexed profiling of circulating RNAs in extracellular vesicles for blood-based GBM characterization. The technology, termed ‘enzyme ZIF-8 complexes for regenerative and catalytic digital detection of RNA’ (EZ-READ), leverages an RNA-responsive transducer to regeneratively convert and catalytically enhance signals from rare RNA targets. Each transducer comprises hybrid complexes – protein enzymes encapsulated within metal organic frameworks – to configure strong catalytic activity and robust protection. Upon target RNA hybridization, the transducer activates directly to liberate catalytic complexes, in a target-recyclable manner; when partitioned within a microfluidic device, these complexes can individually catalyze strong chemifluorescence reactions for digital RNA quantification. The EZ-READ platform thus enables programmable and reliable RNA detection, across different-sized RNA subtypes (miRNA and mRNA), directly in sample lysates. When clinically evaluated, the EZ-READ platform established composite signatures for accurate blood-based GBM diagnosis and subtyping.
- Top Cited PapersOpen Access
- 31 March 2023
- Published by Springer Nature in Nature Reviews Bioengineering
- Vol. 1 (7) , 481-498
Analytical device miniaturization for the detection of circulating biomarkers
Diverse (sub)cellular materials are secreted by cells into the systemic circulation at different stages of disease progression. These circulating biomarkers include whole cells, such as circulating tumour cells, subcellular extracellular vesicles and cell-free factors such as DNA, RNA and proteins. The biophysical and biomolecular state of circulating biomarkers carry a rich repertoire of molecular information that can be captured in the form of liquid biopsies for disease detection and monitoring. In this Review, we discuss miniaturized platforms that allow the minimally invasive and rapid detection and analysis of circulating biomarkers, accounting for their differences in size, concentration and molecular composition. We examine differently scaled materials and devices that can enrich, measure and analyse specific circulating biomarkers, outlining their distinct detection challenges. Finally, we highlight emerging opportunities in biomarker and device integration and provide key future milestones for their clinical translation.
- 31 March 2023
- Published by Springer Nature in Nature Reviews Bioengineering
- Vol. 1 (7) , 481-498
Top Cited PapersOpen AccessAnalytical device miniaturization for the detection of circulating biomarkers
Diverse (sub)cellular materials are secreted by cells into the systemic circulation at different stages of disease progression. These circulating biomarkers include whole cells, such as circulating tumour cells, subcellular extracellular vesicles and cell-free factors such as DNA, RNA and proteins. The biophysical and biomolecular state of circulating biomarkers carry a rich repertoire of molecular information that can be captured in the form of liquid biopsies for disease detection and monitoring. In this Review, we discuss miniaturized platforms that allow the minimally invasive and rapid detection and analysis of circulating biomarkers, accounting for their differences in size, concentration and molecular composition. We examine differently scaled materials and devices that can enrich, measure and analyse specific circulating biomarkers, outlining their distinct detection challenges. Finally, we highlight emerging opportunities in biomarker and device integration and provide key future milestones for their clinical translation.
- Open Access
- 28 June 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-17
A degradative to secretory autophagy switch mediates mitochondria clearance in the absence of the mATG8-conjugation machinery
PINK1-Parkin mediated mitophagy, a selective form of autophagy, represents one of the most important mechanisms in mitochondrial quality control (MQC) via the clearance of damaged mitochondria. Although it is well known that the conjugation of mammalian ATG8s (mATG8s) to phosphatidylethanolamine (PE) is a key step in autophagy, its role in mitophagy remains controversial. In this study, we clarify the role of the mATG8-conjugation system in mitophagy by generating knockouts of the mATG8-conjugation machinery. Unexpectedly, we show that mitochondria could still be cleared in the absence of the mATG8-conjugation system, in a process independent of lysosomal degradation. Instead, mitochondria are cleared via extracellular release through a secretory autophagy pathway, in a process we define as Autophagic Secretion of Mitochondria (ASM). Functionally, increased ASM promotes the activation of the innate immune cGAS-STING pathway in recipient cells. Overall, this study reveals ASM as a mechanism in MQC when the cellular mATG8-conjugation machinery is dysfunctional and highlights the critical role of mATG8 lipidation in suppressing inflammatory responses.
- 28 June 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-17
Open AccessA degradative to secretory autophagy switch mediates mitochondria clearance in the absence of the mATG8-conjugation machinery
PINK1-Parkin mediated mitophagy, a selective form of autophagy, represents one of the most important mechanisms in mitochondrial quality control (MQC) via the clearance of damaged mitochondria. Although it is well known that the conjugation of mammalian ATG8s (mATG8s) to phosphatidylethanolamine (PE) is a key step in autophagy, its role in mitophagy remains controversial. In this study, we clarify the role of the mATG8-conjugation system in mitophagy by generating knockouts of the mATG8-conjugation machinery. Unexpectedly, we show that mitochondria could still be cleared in the absence of the mATG8-conjugation system, in a process independent of lysosomal degradation. Instead, mitochondria are cleared via extracellular release through a secretory autophagy pathway, in a process we define as Autophagic Secretion of Mitochondria (ASM). Functionally, increased ASM promotes the activation of the innate immune cGAS-STING pathway in recipient cells. Overall, this study reveals ASM as a mechanism in MQC when the cellular mATG8-conjugation machinery is dysfunctional and highlights the critical role of mATG8 lipidation in suppressing inflammatory responses.
- 12 September 2021
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 194, 113629
Accessible detection of SARS-CoV-2 through molecular nanostructures and automated microfluidics
- 12 September 2021
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 194, 113629
Accessible detection of SARS-CoV-2 through molecular nanostructures and automated microfluidics
- Open Access
- 18 July 2021
- Published by Wiley in Advanced Science
- Vol. 8 (18) , 2101155
Collaborative Equilibrium Coupling of Catalytic DNA Nanostructures Enables Programmable Detection of SARS‐CoV‐2
Accessible and adaptable nucleic acid diagnostics remains a critical challenge in managing the evolving COVID‐19 pandemic. Here, an integrated molecular nanotechnology that enables direct and programmable detection of SARS‐CoV‐2 RNA targets in native patient specimens is reported. Termed synergistic coupling of responsive equilibrium in enzymatic network (SCREEN), the technology leverages tunable, catalytic molecular nanostructures to establish an interconnected, collaborative architecture. SCREEN mimics the extraordinary organization and functionality of cellular signaling cascades. Through programmable enzyme–DNA nanostructures, SCREEN activates upon interaction with different RNA targets to initiate multi‐enzyme catalysis; through system‐wide favorable equilibrium shifting, SCREEN directly transduces a single target binding into an amplified electrical signal. To establish collaborative equilibrium coupling in the architecture, a computational model that simulates all reactions to predict overall performance and optimize assay configuration is developed. The developed platform achieves direct and sensitive RNA detection (approaching single‐copy detection), fast response (assay reaction is completed within 30 min at room temperature), and robust programmability (across different genetic loci of SARS‐CoV‐2). When clinically evaluated, the technology demonstrates robust and direct detection in clinical swab lysates to accurately diagnose COVID‐19 patients.
- 18 July 2021
- Published by Wiley in Advanced Science
- Vol. 8 (18) , 2101155
Open AccessCollaborative Equilibrium Coupling of Catalytic DNA Nanostructures Enables Programmable Detection of SARS‐CoV‐2
Accessible and adaptable nucleic acid diagnostics remains a critical challenge in managing the evolving COVID‐19 pandemic. Here, an integrated molecular nanotechnology that enables direct and programmable detection of SARS‐CoV‐2 RNA targets in native patient specimens is reported. Termed synergistic coupling of responsive equilibrium in enzymatic network (SCREEN), the technology leverages tunable, catalytic molecular nanostructures to establish an interconnected, collaborative architecture. SCREEN mimics the extraordinary organization and functionality of cellular signaling cascades. Through programmable enzyme–DNA nanostructures, SCREEN activates upon interaction with different RNA targets to initiate multi‐enzyme catalysis; through system‐wide favorable equilibrium shifting, SCREEN directly transduces a single target binding into an amplified electrical signal. To establish collaborative equilibrium coupling in the architecture, a computational model that simulates all reactions to predict overall performance and optimize assay configuration is developed. The developed platform achieves direct and sensitive RNA detection (approaching single‐copy detection), fast response (assay reaction is completed within 30 min at room temperature), and robust programmability (across different genetic loci of SARS‐CoV‐2). When clinically evaluated, the technology demonstrates robust and direct detection in clinical swab lysates to accurately diagnose COVID‐19 patients.
- Open Access
- 30 June 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-12
Surfactant-guided spatial assembly of nano-architectures for molecular profiling of extracellular vesicles
The controlled assembly of nanomaterials into desired architectures presents many opportunities; however, current preparations lack spatial precision and versatility in developing complex nano-architectures. Inspired by the amphiphilic nature of surfactants, we develop a facile approach to guide nanomaterial integration – spatial organization and distribution – in metal-organic frameworks (MOFs). Named surfactant tunable spatial architecture (STAR), the technology leverages the varied interactions of surfactants with nanoparticles and MOF constituents, respectively, to direct nanoparticle arrangement while molding the growing framework. By surfactant matching, the approach achieves not only tunable and precise integration of diverse nanomaterials in different MOF structures, but also fast and aqueous synthesis, in solution and on solid substrates. Employing the approach, we develop a dual-probe STAR that comprises peripheral working probes and central reference probes to achieve differential responsiveness to biomarkers. When applied for the direct profiling of clinical ascites, STAR reveals glycosylation signatures of extracellular vesicles and differentiates cancer patient prognosis.
- 30 June 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-12
Open AccessSurfactant-guided spatial assembly of nano-architectures for molecular profiling of extracellular vesicles
The controlled assembly of nanomaterials into desired architectures presents many opportunities; however, current preparations lack spatial precision and versatility in developing complex nano-architectures. Inspired by the amphiphilic nature of surfactants, we develop a facile approach to guide nanomaterial integration – spatial organization and distribution – in metal-organic frameworks (MOFs). Named surfactant tunable spatial architecture (STAR), the technology leverages the varied interactions of surfactants with nanoparticles and MOF constituents, respectively, to direct nanoparticle arrangement while molding the growing framework. By surfactant matching, the approach achieves not only tunable and precise integration of diverse nanomaterials in different MOF structures, but also fast and aqueous synthesis, in solution and on solid substrates. Employing the approach, we develop a dual-probe STAR that comprises peripheral working probes and central reference probes to achieve differential responsiveness to biomarkers. When applied for the direct profiling of clinical ascites, STAR reveals glycosylation signatures of extracellular vesicles and differentiates cancer patient prognosis.
- Open Access
- 19 March 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (12) , eabe5940
Catalytic amplification by transition-state molecular switches for direct and sensitive detection of SARS-CoV-2
Transition-state molecular switches enable hyper responsive detection of SARS-CoV-2 in native clinical samples.
- 19 March 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (12) , eabe5940
Open AccessCatalytic amplification by transition-state molecular switches for direct and sensitive detection of SARS-CoV-2
Transition-state molecular switches enable hyper responsive detection of SARS-CoV-2 in native clinical samples.